Tech Center 1600 • Art Units: 1632 1656 1678
This examiner grants 66% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17929124 | METHODS AND COMPOSITIONS FOR MODULATING A GENOME | Non-Final OA | FLAGSHIP PIONEERING INNOVATIONS VI, LLC |
| 17786168 | GENOME EDITING USING REVERSE TRANSCRIPTASE ENABLED AND FULLY ACTIVE CRISPR COMPLEXES | Final Rejection | MASSACHUSETTS INSTITUTE OF TECHNOLOGY |
| 17725407 | METHODS AND COMPOSITIONS FOR THE POSITIVE SELECTION OF PROTEIN DESTABILIZERS | Final Rejection | Dana-Farber Cancer Institute, Inc. |
| 17816637 | TRANSFORMATIONAL IMMUNE DIAGNOSTICS | Final Rejection | Arizona Board of Regents on Behalf of Arizona State University |
| 17997453 | ALBUMIN DRUG CONJUGATES AND USE THEREOF FOR THE TREATMENT OF CANCER | Non-Final OA | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM |
| 17737044 | LIGHT-GENERATING FUSION PROTEINS CAPABLE OF SELF-ACTIVATION | Non-Final OA | Technion Research & Development Foundation Limited |
| 18507709 | Engineered CRISPR-Cas9 nucleases with Altered PAM Specificity | Final Rejection | The General Hospital Corporation |
| 18137921 | INTRINSICALLY DISORDERED PROTEINS FOR EXTRACTION OF NUCLEIC ACIDS | Non-Final OA | UNM Rainforest Innovations |
| 17905583 | IN VIVO mRNA DISPLAY: LARGE-SCALE PROTEOMICS BY NEXT GENERATION SEQUENCING | Non-Final OA | The Trustees of Columbia University in the City of New York |
| 18040810 | CELLULOSE BINDING DOMAIN (CBD) CELL EFFECTOR PROTEIN (CEP) CHIMERA, FOR THE TISSUE ENGINEERING | Non-Final OA | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
| 17927164 | SUBTILASE VARIANTS AND COMPOSITIONS COMPRISING SAME | Non-Final OA | Novozymes A/S |
| 18037934 | THERMOTOLERANT PROTEIN GLUTAMINASE | Non-Final OA | AMANO ENZYME INC. |
| 18161654 | RECOMBINATION-BASED DNA ASSEMBLY METHODS AND COMPOSITIONS | Non-Final OA | INTEGRATED DNA TECHNOLOGIES, INC. |
| 17794320 | METHODS OF NUCLEIC ACID SYNTHESIS | Non-Final OA | Nuclera Ltd |
| 17905911 | Engineered PlyAB Nanopores and Uses Thereof | Non-Final OA | Rijksuniversiteit Groningen |
| 18065810 | NOVEL MICROORGANISM FOR POLYSTYRENE BIODEGRADATION | Final Rejection | INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY |
| 17750061 | CHEMICALLY INDUCIBLE POLYPEPTIDE POLYMERIZATION | Non-Final OA | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts |
| 18058712 | COMPOSITIONS AND METHODS FOR INHIBITING VASCULAR SMOOTH MUSCLE CELL PROLIFERATION | Non-Final OA | Westfälische Wilhelms-Universität Münster |
| 17628023 | METHOD FOR EVALUATING STATE OF CELL DIFFERENTIATION | Non-Final OA | Cyto-Facto Inc. |
| 17587643 | SYSTEMS AND METHODS FOR ASSESSING A TARGET MOLECULE | Non-Final OA | AXBIO INC. |
| 17276619 | DEPLETING UNWANTED RNA SPECIES | Non-Final OA | QIAGEN Sciences, LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy